Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(17%)
Results Posted
29%(2 trials)

Phase Distribution

Ph not_applicable
5
42%
Ph phase_3
2
17%
Ph phase_4
4
33%
Ph phase_2
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
2(16.7%)
Phase 4Post-market surveillance
4(33.3%)
N/ANon-phased studies
5(41.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Recruiting2
Not yet recruiting1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (8.3%)
Phase 32 (16.7%)
Phase 44 (33.3%)
N/A5 (41.7%)

Trials by Status

not_yet_recruiting18%
withdrawn18%
unknown18%
recruiting217%
completed758%

Recent Activity

2 active trials
Showing 5 of 12
not_yet_recruitingphase_2

A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease

NCT07078955
recruitingphase_4

Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.

NCT06939959
completednot_applicable

Acupoint Therapy Device for Dry Eye

NCT06720428
recruitingphase_4

Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors

NCT06017362
completednot_applicable

Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate

NCT03374306
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07078955Phase 2

A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease

Not Yet Recruiting
NCT06939959Phase 4

Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.

Recruiting
NCT06720428Not Applicable

Acupoint Therapy Device for Dry Eye

Completed
NCT06017362Phase 4

Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors

Recruiting
NCT03374306Not Applicable

Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate

Completed
NCT06358456Not Applicable

Influence of Artificial Tears on Keratometry and Biometry Measurements With Different Devices

Completed
NCT04515329Phase 4

Tear Film Markers in Dry Eye Syndrome

Withdrawn
NCT05425914Phase 3

Impact of Vitamin D3 Supplementation in Non-Sjogren Dry Eye Patients With Low Serum Vitamin D Level

Completed
NCT01797822Phase 4

Effects of Dry Eye Treatments on the Ocular Surface

Completed
NCT03406689Not Applicable

Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections

Completed
NCT01349452Not Applicable

Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis

Completed
NCT00534391Phase 3

Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and Curettage

Unknown

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12